Berrak zihinler için yalın, zengin, bağımsız bir Türkçe dijital medya üyeliği.
Ücretsiz Kaydol →
loss ile ilgili hikayeler
• Eli Lilly reported revenues of $7.81 billion in Q1 for earnings of $2.62 per share, as shares rose 3% following reports that the pharma giant's tirzepatide drug had yielded impressive results with Type 2 diabetes patients' weight loss.
29 Nis 2022